ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 255105 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 255105; 2) Community: the network communities that were significantly associated with the response to NSC 255105; 3) Molecule: the relationships between components within communities and NSC 255105; 4) MDR: the compounds that were significantly associated with the NSC 255105.

NSC Compound Enrichment Correlation
NSC 163664 Arsinothious acid, dimethyl-, 2,4-pyrimidinediyl ester (9CI) 0.0133299224082803 0.61539085
NSC 266046 Oxaliplatin 0.0135714101922724 0.33826078
NSC 622586 Null 0.0135714101922724 0.15475323
NSC 643027 Diethyl p-phenoxybenzalmalonate 0.0135714101922724 0.47837619
NSC 657271 (+/-) Ethyl cis-2-(3,4-dihydroxyphenyl) cyclopropane-carboxylate 0.0135714101922724 0.35530088
NSC 706992 Null 0.0135714101922724 -0.13032408
NSC 726217 Combretastatin A4-analogue 0.0135714101922724 0.16380727
NSC 726578 Null 0.0135714101922724 0.19390264
NSC 743532 Null 0.0135714101922724 -0.10564934
NSC 753598 Null 0.0135714101922724 0.31357253
Total:61  Current:22    [First] [Prev] [Next] [Last]